Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 95 citing Hudson: Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and.... (0.10 sec) 

Advanced glycation end products and diabetic complications


AW Stitt, AJ Jenkins, ME Cooper - eid, 2002 - Informa Pharma Science
1. Introduction 2. Biochemistry of advanced glycation end product formation in biological systems
3. Role of advanced glycation end products in cellular systems 4. Advanced glycation end products
in microangiopathy 5. Diabetes-related macroangiopathy 6. Non-vascular-related ...
Cited by 89 - Related articles - All 4 versions

The role of advanced glycation in the pathogenesis of diabetic retinopathy


AW Stitt - Experimental and molecular pathology, 2003 - Elsevier
Retinopathy is one of the commonest microvascular complications of diabetes and is still the
prevailing cause of registerable blindness in the working population of developed countries.
The clinicopathology of microvascular lesions and the dysregulation of an array of ...
Cited by 85 - Related articles - All 5 versions

Blockade of receptor for advanced glycation endproducts: a new target for …


BI Hudson, LG Bucciarelli, T Wendt, T Sakaguchi, E … - Archives of Biochemistry …, 2003 - Elsevier
The glycation and oxidation of proteins/lipids leads to the generation of a new class of biologically
active moieties, the advanced glycation endproducts (AGEs). Recent studies have elucidated
that carboxymethyllysine (CML) adducts of proteins/lipids are a highly prevalent AGE in ...
Cited by 81 - Related articles - All 4 versions

RAGE: a novel target for drug intervention in diabetic vascular disease


BI Hudson, AM Schmidt - Pharmaceutical research, 2004 - Springer
Received January 11, 2004; accepted March 10, 2004 At high levels as seen in diabetes, glucose
reacts with and forms adducts (advanced glycation end products; AGEs) on macromolecules
including proteins and DNA, eliciting cellular dysfunction and leading to vascular disease. ...
Cited by 68 - Related articles - BL Direct - All 4 versions

The functional− 374 T/A RAGE gene polymorphism is associated with proteinuria …


K Pettersson-Fernholm, C Forsblom, BI Hudson, M … - Diabetes, 2003 - Am Diabetes Assoc
The hyperglycemic milieu in diabetes results in the formation of advanced glycation end products
(AGEs) that predominantly act through specific receptors, particularly the receptor for AGEs
(RAGE). Two functional polymorphisms in the promoter of the RAGE gene (−429 T/C and ...
Cited by 63 - Related articles - BL Direct - All 6 versions

Amphoterin as an extracellular regulator of cell motility: from discovery to disease


HJ Huttunen, H Rauvala - Journal of internal medicine, 2004 - interscience.wiley.com
It is also possible that your web browser is not configured or not able to display style sheets.
In this case, although the visual presentation will be degraded, the site should continue to be
functional. We recommend using the latest version of Microsoft or Mozilla web browser to ...
Cited by 68 - Related articles - BL Direct - All 5 versions

Genetic Studies of Late Diabetic Complications


JJ Rogus, JH Warram, AS Krolewski - Diabetes, 2002 - Am Diabetes Assoc
Genes play a role in many processes underlying late diabetic complications, but efforts to identify
genetic variants have produced disappointing and contradictory results. Here, we evaluate whether
the study designs and analytic methods commonly being used are optimal for finding ...
Cited by 43 - Related articles - BL Direct - All 4 versions

The clinical relevance of advanced glycation endproducts (AGE) and recent …

- rug.nl [PDF] 
AJ Smit, HL Lutgers - Current medicinal chemistry, 2004 - ingentaconnect.com
Abstract: Advanced glycation endproducts (AGE) are a class of compounds resulting from glycation
and oxidation of proteins, lipids or nucleic acids. Glycation is the non-enzymatic addition or insertion
of saccharide derivatives to these molecules. This leads to the formation of intermediary ...
Cited by 41 - Related articles - BL Direct - All 10 versions

N (carboxymethyl) lysine as a biomarker for microvascular complications in type 2 …


MP Wautier, P Massin, PJ Guillausseau, M Huijberts, … - Diabetes and Metabolism, 2003 - Elsevier
Hyperglycemia is linked to vascular dysfunction in patients with diabetes mellitus, either directly
or through advanced glycation end product (AGE) formation. Experimental evidence has indicated
the possible involvement of AGEs in the genesis of vascular complications. We ...
Cited by 42 - Related articles - BL Direct - All 3 versions

Diabetic vascular disease: it's all the RAGE


BI Hudson, T Wendt, LG Bucciarelli, LL Rong, … - Antioxidants & Redox …, 2005 - liebertonline.com
D IABETES MELLITUS is a chronic metabolic disorder char- acterized by an inherited and/or
acquired deficiency in the production or effect of insulin. This deficiency results in an increase
in blood glucose levels, which in turn may dam- age the vasculature and other target ...
Cited by 39 - Related articles - BL Direct - All 3 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google